Reply

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 684-685

  Chalmers, John ^a   Chairmen, Alberto Zanchetti ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026171480     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00016     Document Type: Letter

References (18)

1. 1 Chalmers J, Zanchetti A: The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens 1996, 14:929-933.
2. 2 Mulrow P, Moser M: A critique of the 1996 report of a World Health Organization expert committee on Hypertension Control [letter]. J Hypertens 1997, 15:000.
3. 3 World Health Organization Expert Committee: Hypertension Control. Geneva: World Health Organization; 1996.
4. 4 MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al.: Blood pressure, stroke and coronary heart disease, Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335: 765-774.
5. 5 MacMahon S, Rodgers A: Blood pressure, antihypertensive treatment and stroke risk. J Hypertens 1994, 12 (suppl 10):S5-S14.
6. 6 Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154-183.
7. 7 World Health Organization Expert Committee: Arterial Hypertension. Geneva: World Health Organization; 1978.
8. 8 Hypertension Detection and Follow-up Program Cooperative Group: Five years findings of the Hypertension Detection and Follow-up Program I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J Am Med Assoc 1979, 242:2562-2571.
9. 9 Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 291:97-104.
10. 10 Management Committee: The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980, i:1261-1267.
11. 11 WHO/ISH Guidelines Subcommittee: 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1993, 11:905-918.
12. 12 Simpson FO: Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996, 14:683-689.
13. 13 MacMahon S: Guidelines for antihypertensive therapy. J Hypertens 1996, 14:691-693.
14. 14 Swales JD: Treating hypertension. J Hypertens 1996, 14:813-814.
15. 15 Zanchetti A, Mancia G: Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach [editorial]. J Hypertens 1996, 14:809-811.
16. 16 Chatellier G, Mënard J: The absolute risk as a guide to influence the treatment decision-making process in mild hypertension. J Hypertens 1997, 15:217-219.
17. 17 Linjer E, Hansson L: Underestimation of the true benefits of antihypertensive treatment. An assessment of some important sources of error. J Hypertens 1997, 15:221-225.
18. 18 Zanchetti A, Mancia G: Strategies for antihypertensive treatment decisions: how to assess benefits? [editorial]. J Hypertens 1997, 15:215-216.